Ching Leang

Ching Leang is a notable inventor based in Skokie, IL, who has made significant contributions to the field of biotechnology. With a total of 3 patents to her name, she has focused on developing genetically engineered microorganisms that enhance biological production processes.

Latest Patents

One of her latest patents is titled "Microorganism with knock-in at acetolactate decarboxylase gene locus." This invention involves a genetically engineered microorganism that incorporates a knock-in of DNA at the acetolactate decarboxylase gene locus. The replacement of this gene with DNA encoding one or more native or nonnative enzymes provides advantages such as fermentation stability and increased production of various products from gaseous substrates. Another significant patent is "Microorganisms and methods for improved biological production of ethylene glycol." This disclosure presents genetically engineered microorganisms and methods that enhance the biological production of ethylene glycol and its precursors. The microorganisms described in this patent can produce ethylene glycol through various metabolic pathways, including 5,10-methylenetetrahydrofolate, oxaloacetate, citrate, malate, and glycine.

Career Highlights

Ching Leang is currently employed at Lanzatech, Inc., where she continues to innovate in the field of biotechnology. Her work focuses on developing sustainable solutions for chemical production through advanced microbial engineering.

Collaborations

Ching collaborates with talented individuals such as Zachary Robert Cowden and Michael Koepke, contributing to a dynamic research environment that fosters innovation.

Conclusion

Ching Leang's contributions to biotechnology through her patents and work at Lanzatech, Inc. highlight her role as a leading inventor in the field. Her innovative approaches to microorganism engineering are paving the way for advancements in sustainable chemical production.

This text is generated by artificial intelligence and may not be accurate.